Advent Capital Management Clovis Oncology, Inc. Transaction History

Advent Capital Management

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$11.63 - $32.67 $58,150 - $163,350	-5,000 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$29.37 - $49.48 $146,850 - $247,399	5,000 New	5,000 $147,000
Q4 2017 Feb 13, 2018	SELL	$57.69 - $84.58 $288,450 - $422,900	-5,000 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$67.17 - $84.81 $335,850 - $424,050	5,000	5,000 $412,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Advent Capital Management , based on Form 13F filings with the SEC.

Stay updated on Advent Capital Management with notifications on news.